TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Nov 27, 2020 11:00 JST
Source:
Brawijaya University
DETAK by Brawijaya University Researchers detects Heart Disease Early and Accurately
MALANG, E. JAVA, Indonesia, Nov 27, 2020 - (ACN Newswire) - Researchers from the Brawijaya University (UB) Medical School in Malang, East Java have developed DETAK, a smartphone application for patients with heart disease. The app works on an AI (artificial intelligence) algorithm, to provide early and accurate detection of heart disease, or acute coronary syndrome, and prevent delays in proper diagnose and treatment.
Acute coronary syndrome describes a host of conditions linked to the sudden, reduced flow of blood to the heart. One such condition is a myocardial infarction, or heart attack, in which cell death results and can lead to damaged or destroyed heart tissue. DETAK was designed to prevent these types of occurrences with early discovery.
"Apart from functioning as an early detection tool encouraging patients to seek treatment, DETAK serves to remind heart disease patients to take their medication and undergo medical checkups regularly," noted Mohammad Saifur Rohman, the lead researcher of cardiovascular study at the UB Medical School. The application also offers informative articles on heart disease and advice for maintaining a healthy heart.
Rohman drew attention to the importance of the early detection service in the application, since delay in the detection of heart disease is a main causal factors in the high number of heart attack cases resulting in death, citing data from the Dr. Saiful Anwar Hospital in Malang. He attributed this delay in detection mostly to a lack of knowledge and awareness of the symptoms of acute coronary syndrome.
For early detection of the ailment, patients using the DETAK app answer several questions related to chest pain they experience and will be notified on where to go to seek help. The app will direct users with high risk of acute coronary syndrome to hospitals with cardiologists on duty, while those with low risk of acute coronary syndrome will be directed to visit nearby health facilities with general practitioners on duty.
The DETAK application has already received the Indonesian Museum of Records (MURI) award, and will soon cover health facilities across Indonesia, with data collection in collaboration with the Indonesian Cardiologist Association (PERKI), Indonesian Medical Association (IDI) and other related facilities.
For further information, contact:
Universitas Brawijaya (UB) Public Relations
www.ub.ac.id and www.prasetya.ub.ac.id.
Source: Brawijaya University
Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Related Press Release
Two new microalgae genera discovered in Indonesian waters
June 24 2025 07:00 JST
Brawijaya University Lecturer Develops IoT-based Chicken Coop Monitoring System
March 20 2025 14:30 JST
Brawijaya University develops data system for climate change monitoring
December 11 2024 15:40 JST
Brawijaya University Prof Develops Early Harvest, High-yield Corn Seeds
September 09 2024 12:00 JST
Brawijaya Academic makes Mulch from Banana Waste and Water Hyacinth
July 15 2024 02:00 JST
Brawijaya University researcher develops honey-processing tech
April 19 2024 23:00 JST
Brawijaya Academic develops DAD App to promote safety at Indonesian Rail Crossings
December 15 2023 22:00 JST
Indonesia's first 8K uncompressed video conference inaugurates 100 Gbps network for education at UB-Universitas Brawijaya
August 11 2023 17:00 JST
Brawijaya-Japan cooperate to establish Research Center of Robotic, AI
June 07 2023 18:00 JST
Brawijaya University develops GIS-based IoT for disaster mitigation
September 30 2022 17:00 JST
More Press release >>
Latest Press Release
Mitsubishi Power Receives Contract for Large-Scale GTCC Project with 2,800 MW Total Output for Taiwan's Tung Hsiao Power Plant
Sep 05, 2025 21:47 JST
Hitachi announces historic $1 billion USD manufacturing investment to power America's energy future through production of critical grid infrastructure
Sep 05, 2025 21:00 JST
NEC participates in Locked Shields 2025 hosted by the NATO Cooperative Cyber Defence Centre of Excellence
Sep 05, 2025 11:20 JST
TANAKA Announces Executive Appointment
Sep 05, 2025 03:00 JST
Honda to Begin Sales of All-new Prelude
Sep 04, 2025 13:20 JST
Signing of Agreement with Yamaguchi Prefecture and Iwakuni City to Construct Module Pack Plant of Automotive Cylindrical Lithium-Ion Batteries
Sep 04, 2025 11:54 JST
NEC to begin proof of concept for early earthquake detection and analysis in Colombia
Sep 04, 2025 11:15 JST
Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025
Sep 04, 2025 10:56 JST
Honda Premieres a New Color Option for Four Large-size Outboard Motors at HISWA In-Water Boat Show 2025 in the Netherlands
Sep 03, 2025 23:50 JST
Toyota Joins TOKYO H2 Project Aiming to Make Tokyo a Global Leader in Hydrogen
Sep 03, 2025 22:39 JST
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event
Sep 03, 2025 12:30 JST
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Sep 03, 2025 11:32 JST
Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025
Sep 03, 2025 11:00 JST
Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure
Sep 03, 2025 10:58 JST
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT
Sep 02, 2025 12:50 JST
Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework "SAFe(R)"
Sep 02, 2025 11:50 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Sep 01, 2025 22:28 JST
DENSO Signs Agreement to Transfer Part of Its Ceramic Product Business
Sep 01, 2025 20:52 JST
Honda to Provide Official Vehicles for World Athletics Championships Tokyo 25 as Official Global Partner
Sep 01, 2025 13:50 JST
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Sep 01, 2025 13:44 JST
More Latest Release >>